Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kingspan Group Plc Remuneration Information 2020

Jul 1, 2020

1958_def-14a_2020-07-01_2e055944-9279-4f22-87c8-58a25aab2b57.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7778R

Kingspan Group PLC

01 July 2020

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically.

To:  Euronext Dublin/FCA

Date: 1 July 2020

Name of applicant: Kingspan Group plc
Name of scheme: Kingspan Group 2008 Share Option Scheme

Kingspan Group 2017 Share Option Scheme
Period of return: From: 01/01/2020 To: 30/06/2020
Balance under scheme from previous return: 830,523
The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: n/a
Number of securities issued/allotted under scheme during period: 368,873
Balance under scheme not yet issued/allotted at end of period 461,650
Total number of securities in issue at the end of the period 183,154,095
Name of contact: Amanda McManus
Address of contact: Kingspan Group plc, Dublin Road, Kingscourt, Co. Cavan, Ireland
Telephone number of contact: 00 353 42 9698000

SIGNED BY   Lorcan Dowd______________________________________________

Director/company secretary/suitably experienced employee/duly authorised officer,

for and on behalf of

Kingspan Group plc   

_______________________________________________

Name of applicant

If you knowingly or recklessly give false or misleading information you may be liable to prosecution.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRBRGDRUBGDGGB